X0206 3 2019-04-08 0 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001773641 Sadr Ahmad C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A CRESTWOOD KY 40014 0 1 0 0 See Remarks Stock Option (Right to Buy) 2.44 2027-02-08 Common Stock 93764 D Stock Option (Right to Buy) 14.95 2028-02-16 Common Stock 28750 D Stock Option (Right to Buy) 13.85 2029-02-07 Common Stock 45000 D These options were granted on February 8, 2017 and vested as to 25% of the shares underlying the options on the first anniversary of the grants, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grants, subject to continued service. These options were granted on February 16, 2018 and vested as to 25% of the shares underlying the options on the first anniversary of the grants, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grants, subject to continued service. These options were granted on February 8, 2019 and will vest as to 25% of the shares underlying the options on the first anniversary of the grants, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grants, subject to continued service. Senior Vice President, Technical Operations /s/ Ahmad Sadr 2019-04-15